Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic Leukemia
Individuals with chronic lymphocytic leukemia (CLL) have significant immune disfunction, often further disrupted by treatment. While currently available COVID-19 vaccinations are highly effective in immunocompetent individuals, they are often poorly immunogenic in CLL patients. It is important to un...
Saved in:
Main Authors: | Zoe L. Lyski, Myung Sun Kim, David Xthona Lee, David Sampson, Hans-Peter Raué, Vikram Raghunathan, Debbie Ryan, Amanda E. Brunton, Mark K. Slifka, William B. Messer, Stephen E. Spurgeon |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Case Reports in Hematology |
Online Access: | http://dx.doi.org/10.1155/2022/6831640 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New-Onset Lichen Planus Induced by the Pfizer COVID-19 Vaccine
by: Fadi A. Alghamdi, et al.
Published: (2022-01-01) -
Delayed-onset anaphylaxis after first dose of Pfizer-BioNTech COVID-19 vaccine
by: Carol Tay, et al.
Published: (2023-09-01) -
A Rare Cutaneous Manifestation: Leukocytoclastic Vasculitis after Pfizer-BioNTech COVID-19 Vaccination
by: Yaritza Serrano Gomez, et al.
Published: (2022-01-01) -
Comparison of IgG and Neutralizing Antibody Response After Pfizer BioNTech COVID-19 Vaccine Among Iraqi Individuals
by: Najat Saeed Hussein, et al.
Published: (2023-06-01) -
Menstrual Changes after COVID-19 Infection and COVID-19 Vaccination
by: Işılay Taşkaldıran, et al.
Published: (2022-01-01)